Mallinckrodt PLC (NYSE American:MNK)
| 7.60 Delayed Data As of Jan 27 |  -0.14 / -1.81%Today’s Change | 0.10 Today|||52-Week Range 31.00 | -1.94% Year-to-Date |
Latest MNK News | Press Releases
No recent news for Mallinckrodt PLC.
Today’s Trading
| Previous close | 7.74 |
| Today’s open | 7.62 |
| Day’s range | 7.59 - 7.62 |
| Volume | 18,445 |
| Average volume (3 months) | 62,476 |
| Market cap | $101.5M |
Data as of 1:25pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +24.23% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -0.21% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.08 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $2.2B |
| Annual profit (last year) | -$717.4M |
| Net profit margin | -32.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
